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Methods
Identifying an appropriate in vitro model to study the effects of microRNA-4705 on S100β expression.
Koch A., Bynagari V., Tan Y., Chopra N.
Transfected SK-MEL-28 Cells
Figure 4. Transfection had no observable effect on the growth of 
SK-MEL-28 cells.
In-silico Identification of microRNA-4705
Conclusions
We detected a distinct band of the right MW that could be S100β. Before 
beginning experiments with microRNA-4705, we need to verify that SK-
MEL-28 cells are an appropriate cell culture model to study S100β
expression, and we need to identify an effective siRNA positive control..
Abstract
Traumatic brain injury (TBI) is caused by external force to the head. In 
addition to the primary injury sustained by the impact, TBI can trigger a 
chronic inflammatory response that causes further tissue damage and 
neuronal death. Following TBI, glial cells of the central nervous system 
secrete elevated levels of the S100β protein. S100β can activate and 
upregulate the Receptor for Advanced Glycation End Products (RAGE). The 
RAGE pathway activates NFκB, a transcription factor involved in production 
of pro-inflammatory cytokines, resulting in infiltration of immune cells from the 
peripheral blood. Unchecked, the inflammatory response is thought to cause 
excessive tissue damage and neuronal death. It is hypothesized that 
downregulation of S100β following TBI may ameliorate damage caused by 
chronic neuroinflammation. Our lab aims to downregulate S100β using 
microRNA. Previously, our lab used bioinformatics to identify a candidate 
microRNA, miR-4705, that might target S100β. We aim to investigate whether 
miR-4705 can downregulate S100β in human SK-MEL-28 cells. Thus far, we 
have gathered evidence that SK-MEL-28 cells express S100β (shown in Fig. 
1). However, we have not been able to demonstrate that S100β siRNA 
downregulates S100β, suggesting that the transfection was unsuccessful. 
These preliminary experiments have served to test the validity of our in vitro 
model for studying S100β expression. Our next steps will be to repeat our 
siRNA experiments and to begin testing the effect of miR-4705 on S100β
expression in SK-MEL-28 cells.
Acknowledgements
Transfection with Silencing RNA
SK-MEL-28 cells
Silencing RNA
TargetScan Predicts Multiple Potential miRNA That May Target 
S100β
Cell Culture. SK-MEL-28 cells cultured at 35˚C using EMEM media. For 
transfection, cells were plated in a 6 well plate at 150-200 K cells/well.
Cell Transfection. Cells were transfected with a complex of lipofectamine, 
Opti-MEM media, and 100 uM silencing RNA.
Cell Harvesting. Cell lysates were harvested with M-PER buffer.
Bradford Assay. We performed a Bradford Assay to calculate the protein 
concentrations of cell lysates.
Western Blot. Based on our previous calculations, we loaded with 15 ug of
cell lysate into each well. We ran gels for 20 minutes, and we probed for β-
actin, α-tubulin, and S100β.
Introduction
S100β Expression in SK-MEL-28 cells
Figure 2. Western 
blot showing a 
distinct band at 
expected MW in SK-
MEL-28 cells, but no 
siRNA knockdown.
Elevated S100β protein levels are linked to TBI pathology. Therefore, 
reduction of S100β is a therapeutic goal. MicroRNA are small RNA
sequences that can inhibit protein translation. We selected a microRNA 
using bioinformatics and self-defined parameters, and we are performing in-
vitro experiments to test whether miRNA-4705 can downregulate S100β.
Figure 1. Based upon self-defined parameters, we identified miRNA-4705 as a potential regulator of 
S100β, and we found that it has predicted complementarity with the 3’ UTR of S100β mRNA.
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Table 2. Hsa-miR-4705 identified as a strong candidate based on self-defined  parameters in miRBase.
Table 1. TargetScan identifies multiple putative miRNA that could target S100b protein by 
targeting the 3'UTR.
Figure 3. siRNA transfection protocol.
